Biocon

Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, we have the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.



Leveraging India’s globally competitive cost base and exceptional scientific people resource, we are advancing our in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical and biotechnology majors through our subsidiary companies, Syngene and Clinigene.



Biocon has rapidly developed a robust drug pipeline, led by monoclonal antibodies and several other molecules at exciting stages in the biopharmaceutical value chain. With the successful commercial launch of our first anti-cancer drug and several promising discovery partnerships in the clinic, we remain committed to scaling new heights in frontier science and achieving new milestones in affordable medicine.



MISSION

To be an integrated biotechnology enterprise of global distinction.



Essential to this mission is excellence in:



- Intellectual asset creation through discovery, research

and development



- State-of-the-art manufacturing capabilities



- Internationally benchmarked quality and regulatory systems



- New medical insight through disease specific

clinical research



- Customer relationship through outstanding products

and services



- Human resource development through training,

mentoring and empowering



- Management of research and business partnerships

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, we offer novel therapies on a platform of affordable innovation.